DK2004204T3 - Behandling af neurodegenerative sygdomme med selenat - Google Patents
Behandling af neurodegenerative sygdomme med selenatInfo
- Publication number
- DK2004204T3 DK2004204T3 DK07718638.5T DK07718638T DK2004204T3 DK 2004204 T3 DK2004204 T3 DK 2004204T3 DK 07718638 T DK07718638 T DK 07718638T DK 2004204 T3 DK2004204 T3 DK 2004204T3
- Authority
- DK
- Denmark
- Prior art keywords
- selenate
- treatment
- neurodegenerative diseases
- neurodegenerative
- diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Inorganic Chemistry (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78724006P | 2006-03-29 | 2006-03-29 | |
| PCT/AU2007/000391 WO2007109851A1 (en) | 2006-03-29 | 2007-03-29 | Treatment of neurodegenerative diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2004204T3 true DK2004204T3 (da) | 2013-01-07 |
Family
ID=38540722
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK07718638.5T DK2004204T3 (da) | 2006-03-29 | 2007-03-29 | Behandling af neurodegenerative sygdomme med selenat |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US8920851B2 (da) |
| EP (1) | EP2004204B1 (da) |
| JP (1) | JP5542430B2 (da) |
| KR (1) | KR101451439B1 (da) |
| CN (1) | CN101478977B (da) |
| AU (1) | AU2007231547B2 (da) |
| BR (1) | BRPI0709033A2 (da) |
| CA (1) | CA2644441C (da) |
| DK (1) | DK2004204T3 (da) |
| ES (1) | ES2394348T3 (da) |
| MX (1) | MX2008012479A (da) |
| NZ (2) | NZ571835A (da) |
| RU (1) | RU2489155C2 (da) |
| WO (1) | WO2007109851A1 (da) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1781315T3 (da) | 2004-08-23 | 2015-04-20 | Yeda Res & Dev | Peptidhæmmere til mediering af stressresponser |
| ES2394348T3 (es) | 2006-03-29 | 2013-01-30 | Velacor Therapeutics Pty Ltd | Tratamiento de enfermedades neurodegenerativas con selenato |
| US20100247679A1 (en) * | 2006-04-24 | 2010-09-30 | Alltech, Inc. | Methods and compositions for altering cell function |
| CA2650309C (en) * | 2006-04-24 | 2014-08-19 | Alltech, Inc. | Selenium-containing compositions and use of the same |
| WO2008119109A1 (en) | 2007-03-29 | 2008-10-09 | Velacor Therapeutics Pty Ltd | Treatment of neurological disorders |
| US8580776B2 (en) * | 2007-07-10 | 2013-11-12 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for treating neurodegenerating diseases |
| WO2009039586A2 (en) * | 2007-09-28 | 2009-04-02 | Powmri Limited | Biomarkers for parkinson's disease |
| WO2009043106A1 (en) * | 2007-10-03 | 2009-04-09 | Velacor Therapeutics Pty Ltd | Inorganic selenium and angiogenesis |
| WO2009043116A1 (en) * | 2007-10-03 | 2009-04-09 | Velacor Therapeutics Pty Ltd | Methods and compositions for the treatment of phosphatase- related disorders |
| CA2706203A1 (en) * | 2007-11-22 | 2009-05-28 | Boehringer Ingelheim International Gmbh | Use of mnk inhibitors for the treatment of alzheimer's disease |
| JP5328244B2 (ja) * | 2008-07-07 | 2013-10-30 | 株式会社ニュージェン・ファーマ | 筋萎縮性側索硬化症治療剤 |
| AU2010304755A1 (en) * | 2009-10-09 | 2012-05-24 | Teva Pharmaceutical Industries, Ltd. | Use of rasagiline for the treatment of Progressive Supranuclear Palsy |
| EP3263127B1 (en) | 2011-05-23 | 2019-08-21 | Yeda Research and Development Co. Ltd | Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same |
| US11046746B2 (en) | 2015-03-26 | 2021-06-29 | Suzhou Auzone Biological Technology Co., Ltd | Method of treatment of cerebral amyloid angiopathy with P75ECD peptide and/or P75ECD-FC fusion protein |
| WO2019216589A1 (ko) * | 2018-05-09 | 2019-11-14 | 한국과학기술연구원 | 타우 관련 질환의 예방 또는 치료용 조성물 |
| CN112654367B (zh) * | 2018-06-29 | 2023-08-04 | 再青春生物医药公司 | 用于年龄相关性和/或变性疾病的药物组合 |
| JP7518852B2 (ja) | 2019-03-26 | 2024-07-18 | シアー， インコーポレイテッド | 生物流体からのタンパク質コロナ分析のための組成物、方法およびシステム、ならびにそれらの使用 |
| WO2023029210A1 (zh) * | 2021-08-31 | 2023-03-09 | 上海交通大学医学院附属瑞金医院 | Pp2a激动剂、清除和/或溶解衰老细胞和/或抑制细胞衰老的化合物用于治疗精神障碍 |
| WO2023057422A1 (en) * | 2021-10-06 | 2023-04-13 | Bayer Aktiengesellschaft | Universal buffer in methods for safe and rapid detection of pathogen infection |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8601915D0 (en) * | 1986-01-27 | 1986-03-05 | Efamol Ltd | Pharmaceutical compositions |
| JPH04247033A (ja) | 1991-02-04 | 1992-09-03 | Yoshitomi Pharmaceut Ind Ltd | 神経細胞壊死抑制剤 |
| US6746678B1 (en) * | 1991-02-22 | 2004-06-08 | Howard K. Shapiro | Method of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with medicaments |
| US5695752A (en) | 1992-09-11 | 1997-12-09 | The Regents Of The University Of California | Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor |
| EP0750511B1 (en) | 1994-03-16 | 2003-06-11 | The Regents Of The University Of California | Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor |
| US6524619B2 (en) | 2000-01-27 | 2003-02-25 | Chronorx, Inc. | Dosage forms useful for modifying conditions and functions associated with hearing loss and/or tinnitus |
| DE10059886A1 (de) | 2000-12-01 | 2002-06-20 | Basf Coatings Ag | Verwendung von wässrigen, physikalisch härtbaren Beschichtungsstoffen auf Polyurethanbasis als Haftgrundierung von Lackierungen |
| GB0202900D0 (en) | 2002-02-07 | 2002-03-27 | Laxdale Ltd | Novel formulations of drugs |
| RU2005106871A (ru) | 2002-08-14 | 2005-10-10 | Вертекс Фармасьютикалз Инкорпорейтед (Us) | Ингибиторы протеинкиназ и их применение |
| MXPA05011524A (es) | 2003-04-30 | 2006-03-21 | Inst For Pharm Discovery Inc | Acidos carboxilicos sustituidos. |
| AU2003904328A0 (en) | 2003-08-13 | 2003-08-28 | Garvan Institute Of Medical Research | Diagnosis and treatment of neurodegenerative disorders |
| WO2005023274A1 (en) | 2003-09-05 | 2005-03-17 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Treatment and prevention of inflammatory disease and mitochondrial dysfunction with high dose selenium |
| US20050142216A1 (en) | 2003-12-31 | 2005-06-30 | Rindlesbach Keith A. | Method for reversing Alzheimer dementia |
| CN101073584B (zh) | 2005-10-14 | 2012-10-10 | 全面技术公司 | 改变细胞功能的方法和组合物 |
| US20080004255A1 (en) | 2005-10-14 | 2008-01-03 | Alltech, Inc. | Methods and compositions for altering cell function |
| ES2394348T3 (es) | 2006-03-29 | 2013-01-30 | Velacor Therapeutics Pty Ltd | Tratamiento de enfermedades neurodegenerativas con selenato |
| AU2007231549A1 (en) | 2006-03-29 | 2007-10-04 | Velacor Therapeutics Pty Ltd | Inorganic selenium for treatment of benign tumors |
-
2007
- 2007-03-29 ES ES07718638T patent/ES2394348T3/es active Active
- 2007-03-29 NZ NZ571835A patent/NZ571835A/en not_active IP Right Cessation
- 2007-03-29 AU AU2007231547A patent/AU2007231547B2/en not_active Ceased
- 2007-03-29 WO PCT/AU2007/000391 patent/WO2007109851A1/en not_active Ceased
- 2007-03-29 KR KR1020087026561A patent/KR101451439B1/ko not_active Expired - Fee Related
- 2007-03-29 US US12/295,270 patent/US8920851B2/en not_active Expired - Fee Related
- 2007-03-29 BR BRPI0709033-1A patent/BRPI0709033A2/pt not_active IP Right Cessation
- 2007-03-29 CN CN2007800122806A patent/CN101478977B/zh not_active Expired - Fee Related
- 2007-03-29 DK DK07718638.5T patent/DK2004204T3/da active
- 2007-03-29 MX MX2008012479A patent/MX2008012479A/es active IP Right Grant
- 2007-03-29 EP EP07718638A patent/EP2004204B1/en not_active Not-in-force
- 2007-03-29 RU RU2008142514/15A patent/RU2489155C2/ru not_active IP Right Cessation
- 2007-03-29 CA CA2644441A patent/CA2644441C/en not_active Expired - Fee Related
- 2007-03-29 JP JP2009501780A patent/JP5542430B2/ja not_active Expired - Fee Related
- 2007-03-29 NZ NZ596244A patent/NZ596244A/xx not_active IP Right Cessation
-
2013
- 2013-11-14 US US14/079,877 patent/US20140141104A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0709033A2 (pt) | 2011-06-21 |
| KR101451439B1 (ko) | 2014-10-16 |
| EP2004204A4 (en) | 2010-06-02 |
| CN101478977B (zh) | 2013-03-27 |
| ES2394348T3 (es) | 2013-01-30 |
| JP5542430B2 (ja) | 2014-07-09 |
| RU2489155C2 (ru) | 2013-08-10 |
| EP2004204B1 (en) | 2012-09-12 |
| CA2644441C (en) | 2014-09-09 |
| KR20090015038A (ko) | 2009-02-11 |
| RU2008142514A (ru) | 2010-05-10 |
| WO2007109851A1 (en) | 2007-10-04 |
| EP2004204A1 (en) | 2008-12-24 |
| NZ596244A (en) | 2013-05-31 |
| US20140141104A1 (en) | 2014-05-22 |
| AU2007231547B2 (en) | 2012-07-12 |
| CN101478977A (zh) | 2009-07-08 |
| CA2644441A1 (en) | 2007-10-04 |
| NZ571835A (en) | 2011-11-25 |
| JP2009532340A (ja) | 2009-09-10 |
| US8920851B2 (en) | 2014-12-30 |
| US20090169649A1 (en) | 2009-07-02 |
| AU2007231547A1 (en) | 2007-10-04 |
| MX2008012479A (es) | 2009-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2004204T3 (da) | Behandling af neurodegenerative sygdomme med selenat | |
| DK2056807T3 (da) | Behandling af inflammatoriske sygdomme | |
| DK1874781T3 (da) | Dihydrothienopyrimidiner til behandling af inflammatoriske sygdomme | |
| DK2182983T3 (da) | Behandling af amyloidogene sygdomme med humaniserede anti-abeta antistoffer | |
| DK2474321T3 (da) | Sammensætninger til behandling af collagenmedierede sygdomme | |
| DK2480574T3 (da) | Anti-cd33-antistoffer og deres anvendelse til immunotargeting i behandlingen af cd33-associerede sygdomme | |
| EP2046349A4 (en) | TREATMENT OF EXCESSIVE NEOVASCULARIZATION | |
| DK2056842T3 (da) | Modificeret galactosylceramid til behandling af cancerøse sygdomme | |
| DK1986633T3 (da) | Behandling af duchennes muskeldystrofi | |
| DK2222272T3 (da) | Behandling af luftvejssygdom | |
| DK2047863T3 (da) | Middel til forebyggelse eller behandling af inflammatoriske sygdomme | |
| DK2091673T3 (da) | Elektromagnetisk behandling af kontaminerede materialer | |
| DK2114447T3 (da) | Forebyggelse og behandling af subkliniks pcvd | |
| BRPI0815551A2 (pt) | Tratamento através de hucbc de doença beta-amiloide | |
| DK2285808T3 (da) | Spiroindolderivater til behandling af parasitsygdomme | |
| DK2373927T3 (da) | Behandling af forbrændingsgas fra affaldsbehandling | |
| DK1685834T3 (da) | Anvendelse af pinolensyre til behandling af obesitet | |
| DK2099446T3 (da) | Fremgangsmåde til behandling af inflammatorisk tarmsygdom | |
| DK2056858T3 (da) | Behandling af lungesygdomstilstande | |
| DK2117565T3 (da) | Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme | |
| DK1981515T3 (da) | MAPC behandling af hjerneskader og -sygdomme | |
| DK2022504T3 (da) | Salve til behandling af hæmorider | |
| BRPI0715728A2 (pt) | tratamento de distérbio cartilaginosos | |
| FI20095600L (fi) | Koostumus ihosairauksien hoitoa varten | |
| DK2222289T3 (da) | Behandling af oral pharyngeal dysphagi |